LES-SVC July Chapter Meeting: "Navigating the Evolving Landscape of Life Sciences Licensing: Trends, Challenges, and Opportunities"

LES-SVC July Chapter Meeting (in-person event):

"Navigating the Evolving Landscape of Life Sciences Licensing: Trends, Challenges, and Opportunities"

   Wednesday, July 23, 2025 |  11:00 AM – 2:00 PM PT
Wilson Sonsini, 650 Page Mill Road, Palo Alto, CA
 Includes 1 CLE credit |  Lunch provided | Free registration

REGISTER ONLINE TODAY!

 Join LES-SVC for a high-impact, in-person event bringing together legal, licensing, and business development leaders shaping the future of life sciences innovation and dealmaking. Hosted at Wilson Sonsini’s Palo Alto HQ, this lunch session delivers a unique combination of data-driven insights, real-world deal experience, and networking with Silicon Valley’s biotech and licensing professionals.

Agenda:

11:00 AM – 12:00 PM: Registration, Lunch, and Networking

12:00 PM – 1:20 PM: Program (Keynote, LES Life Sciences Survey Preview, Panel Discussion)

1:20 PM – 2:00 PM: Networking

Keynote Conversation:
Ian B. Edvalson, Partner, Technology Transactions at Wilson Sonsini (bio), will kick off the event with a strategic talk on building durable relationships in today’s high-stakes licensing environment.

 Data Spotlight:

Natalie J. Punnilathil, Director of Business Development & Licensing at Parker Institute for Cancer Immunotherapy, will provide a brief preview of the 2025 LES Life Sciences Royalty Rates and Deal Terms Survey, which offers exclusive benchmarking data and trends across upfronts, royalties, milestones, and more.

Expert Panel Discussion:

Join a panel discussion moderated by Natalie that will bring together diverse experts to discuss the current state of life sciences licensing, exploring the dominant trends in deal-making, from upfront payments and royalty structures to the most sought-after therapeutic areas and technologies. Panelists will highlight the critical challenges faced by both licensors and licensees, and explore key trends, deal dynamics, early-stage valuation challenges, and emerging opportunities, offering actionable advice for navigating this evolving field.

Panelists:

• Cristina Ghenoiu, Partner, Mubadala Capital

• Timothy Herpin, Fractional CBO to multiple biotech startups

• Todd Pazdera, Director, Business Development, UCSF Innovation Ventures

• David Pirko, Partner, Technology Transactions, WSGR

Key Takeaways:

• Discover the latest trends and strategies shaping life sciences licensing deals in 2025

• Learn how global forces and economic shifts are impacting negotiations and dealmaking

• Hear expert insights on the breakthrough technologies and emerging therapeutic areas driving industry partnerships

• Get actionable tips for navigating challenges and building successful licensing relationships in a changing landscape

CLE Credit: 1 CLE credit available (AZ, CA, CO, ID, IL, NY, OR, TX, VA, WA, WI)
Audience: Life sciences innovators, investors, business development & IP professionals

Thank you to our sponsor for hosting this event: